| Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Raltegravir Potassium A Kambayashi, M Iida, M Ishihara, Y Takahashi, B Abrahamsson, ... Journal of Pharmaceutical Sciences, 2024 | | 2024 |
| Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report X Pepin, S Arora, L Borges, M Cano-Vega, T Carducci, P Chatterjee, ... Molecular Pharmaceutics 21 (8), 3697-3731, 2024 | | 2024 |
| A Stratified Analysis of Supersaturation and Precipitation Effects Based on the Refined Developability Classification System (rDCS) K Beran, E Hermans, R Holm, K Sepassi, J Dressman Journal of Pharmaceutical Sciences, 2024 | | 2024 |
| Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Fexofenadine NA Charoo, N Selvasudha, ZN Kath, B Abrahamsson, R Cristofoletti, ... Journal of Pharmaceutical Sciences, 2024 | | 2024 |
| Silicon-Based Piezo Micropumps Enable Fully Flexible Drug Delivery Patterns D Plano, S Kibler, N Rudolph, O Zett, J Dressman Journal of Pharmaceutical Sciences 113 (6), 1555-1565, 2024 | | 2024 |
| Enteric-Coated Capsules Providing Reliable Site-Specific Drug Delivery to the Distal Ileum M Grimm, L Großmann, S Senekowitsch, A Rump, JE Polli, J Dressman, ... Molecular Pharmaceutics, 2024 | | 2024 |
| Relative performance of volume of distribution prediction methods for lipophilic drugs with uncertainty in logP value AL Coutinho, R Cristofoletti, F Wu, A Al Shoyaib, J Dressman, JE Polli Pharmaceutical Research, 1-18, 2024 | 1 | 2024 |
| Is there a fast track (“Darmstrasse”) for fluids in the small intestine? Evidence from magnetic resonance imaging L Großmann, K Springub, L Krüger, F Winter, A Rump, ML Kromrey, ... European Journal of Pharmaceutics and Biopharmaceutics 198, 114277, 2024 | 1 | 2024 |
| Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias V Eberlein, S Rosencrantz, J Finkensieper, JK Besecke, Y Mansuroglu, ... Frontiers in Immunology 15, 1382318, 2024 | 1 | 2024 |
| An In Vitro Model for Release of Acetaminophen When an Overdose is Ingested Orally M Chronowska, J Dressman Dissolution Technologies 31 (1), 14-24, 2024 | 1 | 2024 |
| A comparison of USP 2 and µDISS Profiler™ apparatus for studying dissolution phenomena of ibuprofen and its salts L Zöller, A Avdeef, E Karlsson, A Borde, S Carlert, C Saal, J Dressman European Journal of Pharmaceutical Sciences 193, 106684, 2024 | 3 | 2024 |
| Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Isavuconazonium Sulfate D Plano, N Rudolph, C Saal, B Abrahamsson, R Cristofoletti, ... Journal of Pharmaceutical Sciences 113 (2), 386-395, 2024 | 1 | 2024 |
| Drug dissolution in oral drug absorption: workshop report K Raines, P Agarwal, P Augustijns, A Alayoubi, L Attia, A Bauer-Brandl, ... The AAPS Journal 25 (6), 103, 2023 | 7 | 2023 |
| Comparative dissolution of Budesonide from four commercially available products for oral administration: implications for interchangeablity J Dressman Dissolution Technol 30, 224-229, 2023 | 5 | 2023 |
| Challenges in permeability assessment for oral drug product development M Koziolek, P Augustijns, C Berger, R Cristofoletti, D Dahlgren, J Keemink, ... Pharmaceutics 15 (10), 2397, 2023 | 4 | 2023 |
| A robust, viable, and resource sparing HPLC-based logP method applied to common drugs AL Coutinho, R Cristofoletti, F Wu, A Al Shoyaib, J Dressman, JE Polli International Journal of Pharmaceutics 644, 123325, 2023 | 4 | 2023 |
| Leveraging the use of in vitro and computational methods to support the development of enabling oral drug products: An InPharma commentary C Reppas, M Kuentz, A Bauer-Brandl, S Carlert, A Dallmann, S Dietrich, ... European Journal of Pharmaceutical Sciences 188, 106505, 2023 | 5 | 2023 |
| Mucosal application of a low-energy electron inactivated respiratory syncytial virus vaccine shows protective efficacy in an animal model V Eberlein, M Ahrends, L Bayer, J Finkensieper, JK Besecke, ... Viruses 15 (9), 1846, 2023 | 2 | 2023 |
| Factors That Influence Sustained Release from Hot-Melt Extrudates Y Mansuroglu, J Dressman Pharmaceutics 15 (7), 1996, 2023 | 3 | 2023 |
| Projection of Target Drug Particle Size in Oral Formulations Using the Refined Developability Classification System (rDCS) K Beran, E Hermans, R Holm, K Sepassi, J Dressman Pharmaceutics 15 (7), 1909, 2023 | 4 | 2023 |
Christos ReppasProfessor of Pharmaceutics, National and Kapodistrian University of Athens在 pharm.uoa.gr 的电子邮件经过验证
